Year archive

Beijing Biostar Pharmaceuticals Co., Ltd. — 2024 filings

All 18 regulatory filings released by Beijing Biostar Pharmaceuticals Co., Ltd. (2563) in 2024, sourced directly from the official regulator.

18 Filings

2024 Period

2024 filings (18)

Filing	Released	Lang
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2024 Regulatory Filings	2024-12-05	English
VOLUNTARY ANNOUNCEMENT - ENTERING INTO MARKETING SERVICE AGREEMENT AND SUPPLEMENTAL AGREEMENT WITH BAHEAL ZHIHE Regulatory Filings	2024-11-14	English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2024 Regulatory Filings	2024-11-06	English
ANNOUNCEMENT OF FINAL OFFER PRICE AND ALLOTMENT RESULTS Capital/Financing Update	2024-10-30	English
ARTICLES OF ASSOCIATION Governance Information	2024-10-30	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2024-10-30	English
IMPLEMENTATION RULES OF THE STRATEGY COMMITTEE OF THE BOARD OF DIRECTORS Governance Information	2024-10-30	English
IMPLEMENTATION RULES OF THE REMUNERATION AND APPRAISAL COMMITTEE OF THE BOARD OF DIRECTORS Remuneration Information	2024-10-30	English
IMPLEMENTATION RULES OF THE NOMINATION COMMITTEE OF THE BOARD OF DIRECTORS Governance Information	2024-10-30	English
IMPLEMENTATION RULES OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS Governance Information	2024-10-30	English
Documents on Display Regulatory Filings	2024-10-23	English
GLOBAL OFFERING Regulatory Filings	2024-10-23	English
GLOBAL OFFERING Capital/Financing Update	2024-10-23	English
PHIP (1st submission) Regulatory Filings	2024-10-18	English
PHIP (1st submission) Audit Report / Information FY 2023	2024-10-18	English
OC Announcement - Appointment Regulatory Filings	2024-08-12	English
Application Proof (1st submission) Audit Report / Information FY 2024	2024-08-12	English
Application Proof (1st submission) Regulatory Filings	2024-08-12	English